Sitka Biopharma Overview
- Founded
-
2013
- Status
-
Out of Business
- Employees
-
4
- Latest Deal Type
-
Out of Business
Sitka Biopharma General Information
Description
Developer of a nano-particle polymer platform technology designed to improve drug absorption for cancer treatments. The company's platform increases the absorption of drugs in difficult-to-penetrate tissues and addresses the absorption challenges of intravesical chemotherapy for bladder cancer, and later intraperitoneal delivery for ovarian cancer, enabling clinicians to transform chemotherapies to benefit patients by enhancing drug efficacy and improving tolerability.
Contact Information
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Primary Office
- 2500 - 1075 West Georgia Street
- Vancouver, British Columbia V6E 3C9
- Canada
+1 (604) 000-0000
Sitka Biopharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 01-Apr-2022 | 00.00 | Completed | Out of Business | ||
| 4. Secondary Transaction - Private | 25-Sep-2020 | 00.00 | Completed | Pre-Clinical Trials | ||
| 3. Later Stage VC | 11-Feb-2019 | 00.00 | 00.00 | Completed | Pre-Clinical Trials | |
| 2. Seed Round | 07-Aug-2016 | $2.4M | $2.4M | Completed | Pre-Clinical Trials | |
| 1. Spin-Off | 03-Dec-2013 | Completed | Pre-Clinical Trials |
Sitka Biopharma Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a nano-particle polymer platform technology designed to improve drug absorption for cancer treatments. The
Drug Delivery
Vancouver, Canada
4
As of 2021
00.00
00000000 00
00.00
000 00
s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
0000 00000000
Debrecen, Hungary
00
As of 0000
00.000
0000000000
00.000
00000
, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut
0000 00000000
Paris, France
00
As of 0000
000.00
00000000000
000.00
Add Comparison
Sitka Biopharma Competitors (52)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BBS Nanotech Theranostics | Venture Capital-Backed | Debrecen, Hungary | 00 | 00.000 | 0000000000 | 00.000 |
| 00000 000000000000 | Venture Capital-Backed | Paris, France | 00 | 000.00 | 00000000000 | 000.00 |
| 0000000 | Venture Capital-Backed | Cambridge, MA | 000 | 00000000000 | 000 | |
| 000000 | Venture Capital-Backed | Seattle, WA | 00 | 00000 | 0000000000 | 00000 |
| 0000000 0000000000 | Venture Capital-Backed | Maastricht, Netherlands | 00 | 000.00 | 0000000000 | 000.00 |
Sitka Biopharma Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Robert Geckeler | Chief Development Officer | ||
| Kaley Wilson Ph.D | Interim Chief Executive Officer & Board Member |
Sitka Biopharma Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Gordon McCauley | CDRD Ventures | Board Member | 000 0000 |
| Jack Geltosky Ph.D | Self | Board Member | 000 0000 |
| Kaley Wilson Ph.D | Self | Interim Chief Executive Officer & Board Member | 000 0000 |
| Karim Lalji | CDRD Ventures | Chairman | 000 0000 |
| Karimah Es Sabar | Quark Venture | Board Member | 000 0000 |
Sitka Biopharma Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
